SR
Sorrento Therapeutics, Inc.
SRNE · OTC
$0.00 +0.00% (+$0.00)
1M -42.86%
Market Cap $496.2K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.01x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 25.98%
EPS growth N/A
FCF growth N/A
Profitability
19 /100
Weak Gross margin 46.77%
Net margin 911.60%
FCF margin 489.37%
Quality
2 /100
Poor ROIC 286.80%
ROA 121.15%
Asset turnover 0.13x
Debt
50 /100
Moderate Current ratio 0.29x
Int. coverage -64.52x
Net debt/EBITDA -0.21x
Stability
50 /100
Moderate Beta 0.12x
Rev. volatility 6.83%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SRNE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Henry H. Ji
Employees
949
Headquarters
San Diego
Upcoming events
06 NOV
Earnings
Upcoming earnings report